Related Experiment Videos
A novel polymorphism in the human interleukin-13 (IL-13) promoter
G J Laundy1, C F Spink, L J Keen
1Division of Transplantation Sciences, University of Bristol, UK.
Summary
Researchers discovered a new single nucleotide polymorphism (SNP) in the human Interleukin-13 (IL-13) gene promoter. This common genetic variation, a C to T change at position -1055, was found in 16.7% of normal cord blood donors.
Area of Science:
- Genetics
- Molecular Biology
- Immunology
Background:
- The Interleukin-13 (IL-13) gene plays a crucial role in immune responses and is implicated in various inflammatory and allergic diseases.
- Understanding genetic variations in the IL-13 promoter is important for elucidating its regulatory mechanisms and association with disease susceptibility.
Purpose of the Study:
- To identify and characterize novel polymorphisms within the promoter region of the human IL-13 gene.
- To determine the allele frequencies of the identified polymorphism in a healthy human population.
Main Methods:
- Polymerase Chain Reaction - Single Strand Conformation Polymorphism (PCR-SSCP) was employed to screen for genetic variations.
- Automated nucleotide sequencing was utilized to confirm and characterize the identified polymorphism.
- Allele frequency analysis was performed on DNA samples from normal cord blood donors.
Main Results:
- A novel single nucleotide polymorphism (SNP) was identified in the human IL-13 promoter at position -1055 (relative to the transcription start site).
- The identified polymorphism involves a cytosine (C) to thymine (T) substitution.
- The allele frequencies in the studied population were 0.833 for the C allele and 0.167 for the T allele.
Conclusions:
- A new C --> T single nucleotide polymorphism at position -1055 in the human IL-13 promoter has been identified.
- This polymorphism is relatively common, with the T allele present in 16.7% of normal cord blood donors.
- Further studies are warranted to investigate the functional significance and potential association of this IL-13 promoter polymorphism with disease phenotypes.